Prism Medico

Prism_Medico26 Apr 2024

Trading

₹

+0.01 (+0.04%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Prism Medico

Prism Medico

Trading

Prism_Medico26 Apr 2024

₹

+0.01 (+0.04%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
05-Feb-2024	BC	PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Dear Sir/Madam With reference	13-Feb-2024
01-Nov-2023	BC	PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Dear Sir/Madam With reference	08-Nov-2023
04-Sep-2023	BC	Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith outcome of m	30-Sep-2023
14-Sep-2023	BC	Annual General Meeting	23-Sep-2023
31-Aug-2023	BC	PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2023 inter alia to consider and approve ? To consider and approve the Di	04-Sep-2023

No Rights has been declared by Prism_Medico

Book Closure

Record Date	Split Date	Purpose
13-Feb-2024	-	PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Dear Sir/Madam With reference
08-Nov-2023	-	PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Dear Sir/Madam With reference
30-Sep-2023	-	Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith outcome of m
23-Sep-2023	01 Jan'1900	Annual General Meeting
04-Sep-2023	-	PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2023 inter alia to consider and approve ? To consider and approve the Di

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Prism Medico & Pharmacy Ltd ₹23.78(+0.01/0.04%)	23.78	+0.01	14.42	-11.10	148.63	0.95
Computer Point Ltd ₹4.70(+0.09/1.95%)	4.70	+0.09	14.10	141.03	470.00	0.42
Ambalal Sarabhai Enterprises Ltd ₹46.82(-1.20/-2.50%)	46.82	-1.20	358.80	117.36	0.00	9.86
Novartis India Ltd ₹1,055.10(+9.20/0.88%)	1,055.10	+9.20	2,605.13	81.60	27.27	3.71
Mysore Petro Chemicals Ltd ₹183.05(-1.05/-0.57%)	183.05	-1.05	120.51	65.66	16.14	1.18
Aegis Logistics Ltd ₹635.95(+35.60/5.93%)	635.95	+35.60	22,321.85	61.80	50.59	10.06

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	2.75	0.03	0.00	1.27	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	2.75	0.03	0.00	1.27	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.01	0.02	0.00	0.00	0.00
Total Income	2.75	0.04	0.02	1.27	0.00	0.00
Total Expenditure	2.55	0.10	0.10	1.25	0.02	0.02
PBIDT	0.20	-0.05	-0.08	0.03	-0.02	-0.02
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	0.19	-0.05	-0.09	0.03	-0.02	-0.02
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	-0.03	0.00	0.00
Reported Profit After Tax	0.19	-0.05	-0.09	0.05	-0.03	-0.02
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.19	-0.05	-0.09	0.05	-0.03	-0.02

EPS (Unit Curr.)	0.31	-0.09	0.00	0.00	-0.04	-0.03
EPS (Adj) (Unit Curr.)	0.31	-0.09	0.00	0.00	-0.04	-0.03
Calculated EPS (Unit Curr.)	0.31	-0.09	-0.15	0.08	-0.05	-0.04
Calculated EPS (Adj) (Unit Curr.)	0.31	-0.09	-0.15	0.08	-0.05	-0.04
Calculated EPS (Ann.) (Unit Curr.)	1.25	-0.36	-0.59	0.33	-0.18	-0.15
Calculated EPS (Adj) (Ann.) (Unit Curr.)	1.25	-0.36	-0.59	0.33	-0.18	-0.15
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	6.06	6.06	6.06	6.06	6.06	6.06
Reserve & Surplus	9.14	8.95	9.01	9.10	6.10	6.39
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	7.27	-166.67	0.00	2.36	0.00	0.00
PBDTM(%)	6.91	-166.67	0.00	2.36	0.00	0.00
PATM(%)	6.91	-166.67	0.00	3.94	0.00	0.00

Column	Dec 19	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18
Gross Sales	9.75	6.60	8.68	16.54	17.11	15.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	9.75	6.60	8.68	16.54	17.11	15.00
Other Operating Income	0.00	0.03	0.03	0.26	0.02	0.00
Other Income	0.03	0.00	0.00	0.05	0.00	0.05
Total Income	9.78	6.62	8.71	16.86	17.13	15.06
Total Expenditure	9.75	6.39	8.54	17.40	16.89	14.69
PBIDT	0.03	0.24	0.17	-0.54	0.24	0.37
Interest	0.07	0.07	0.00	0.04	0.03	0.03
PBDT	-0.04	0.17	0.17	-0.58	0.21	0.34
Depreciation	0.00	0.09	0.09	0.15	0.07	0.07
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.04	-0.05	0.00	0.00	0.00
Deferred Tax	0.00	-0.05	0.00	0.00	0.00	0.00
Reported Profit After Tax	-0.04	0.09	0.13	-0.73	0.15	0.28
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	-0.04	0.09	0.13	-0.73	0.15	0.28

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.04	0.09	0.13	-0.73	0.15	0.28

EPS (Unit Curr.)	-0.07	0.15	0.21	-1.21	0.24	0.46
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	6.06	6.06	6.06	6.06	6.06	6.06

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	0.31	3.64	1.96	-3.26	1.40	2.47
PBDTM(%)	-0.41	2.58	1.96	-3.51	1.23	2.27
PATM(%)	-0.41	1.36	1.50	-4.41	0.88	1.87

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	6.06	6.06	6.06	6.06	6.06	6.06
Reserves Total	9.10	6.49	6.86	6.99	7.09	6.72
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	15.16	12.55	12.92	13.05	13.15	12.78
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	15.16	12.55	12.92	13.05	13.15	12.78
APPLICATION OF FUNDS :
Gross Block	0.04	0.05	0.22	0.22	0.22	0.22
Less : Accumulated Depreciation	0.00	0.00	0.16	0.15	0.13	0.11
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.04	0.05	0.06	0.07	0.09	0.11
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	1.94	1.94	10.00	11.25
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	6.77	6.77	4.85	0.05	0.96	0.89
Sundry Debtors	4.76	4.88	13.51	18.34	3.76	0.00
Cash and Bank	0.10	0.06	0.08	0.11	0.12	0.04
Loans and Advances	3.52	0.63	1.04	1.07	2.05	0.65
Total Current Assets	15.14	12.34	19.49	19.57	6.89	1.57
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.23	0.02	8.62	8.53	3.76	0.08
Provisions	0.00	0.00	0.00	0.00	0.06	0.01
Total Current Liabilities	0.23	0.02	8.62	8.53	3.82	0.09
Net Current Assets	14.91	12.32	10.87	11.04	3.07	1.49
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.21	0.19	0.06	0.01	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.07
Net Deferred Tax	0.21	0.19	0.06	0.01	0.00	-0.07
Total Assets	15.16	12.56	12.93	13.06	13.16	12.78
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.06	0.08	0.11	0.12	0.04
Net Cash from Operating Activities	2.95	-2.38	-0.05	-4.36	-1.23
Net Cash Used In Investing Activities	-2.91	2.35	0.02	4.36	1.25
Net Cash Used In Financing Activities	0.00	0.00	0.00	0.00	0.06
Net Inc./Dec In Cash And Cash Equivalents	0.04	-0.03	-0.03	-0.01	0.08
Cash And Cash Equivalents At End Of The Year	0.10	0.06	0.08	0.11	0.12

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

25.00%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

75.00%

**Promoter pledged shareholding 25.00%

About Prism Medico & Pharmacy Ltd

Prism Medico & Pharmacy Ltd is in the Trading sector, having a market capitalization of Rs. 14.42 crores. It has reported a sales of Rs. 2.75 crores and a net profit of Rs. 0.19 crores for the quarter ended December 2018. The company management includes , Sameer Gupta,Davender Singh,Pradeep Kumar,Sakshi Laller,Vishwambhar Dayal Gupta,Dinesh Kumar (Prism Medico & Pharmacy Ltd) among others.

Chairman

Registered office

D-118 Industrial Area,Phase VII,Mohali,Punjab,160055

FAX :

Background

Incorporation Year2002

Face Value₹10

Market Lot50

How to buy Prism Medico shares on nse?

To buy Prism Medico shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Prism Medico share price today?

The Prism Medico shares price on nse is Rs.23.78 today.

What is the market cap of Prism Medico shares on BSE ?

The company has a market capitalization of Rs.14.42Cr

What is the PE & PB ratio of Prism Medico shares ?

PE is 148.63 and PB is 0.95

What is the 52 Week High and Low of Prism Medico shares?

Prism Medico stock price high: Rs.39.2 Prism Medico stock price low: Rs.22.05